This page in English

Juan Du

Postdoc

Besöksadress : Nobels Väg 16 171 77 Stockholm
Postadress : Institutionen för mikrobiologi, tumör- och cellbiologi (MTC), C1, Lars Engstrand grupp, Box 280 171 77 Stockholm
Leveransadress : Nobels Väg 16 171 77 Stockholm

Publikationer

Nanoparticles for immune system targeting
Du J, Zhang Ys, Hobson D, Hydbring P
Drug discovery today 2017;():-

The type III secretion system apparatus determines the intracellular niche of bacterial pathogens
Du J, Reeves Az, Klein Ja, Twedt Dj, Knodler La, Lesser Cf
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2016;113(17):4794-9

Engineering Escherichia coli into a protein delivery system for mammalian cells
Reeves Az, Spears We, Du J, Tan Ky, Wagers Aj, Lesser Cf
ACS synthetic biology 2015;4(5):644-54

Human papillomavirus prevalence is high in oral samples of patients with tonsillar and base of tongue cancer
Nordfors C, Vlastos A, Du J, Ahrlund-richter A, Tertipis N, Grün N, et al
Oral oncology 2014;50(5):491-7

CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma
Nordfors C, Grün N, Tertipis N, Ährlund-richter A, Haeggblom L, Sivars L, et al
European journal of cancer (Oxford, England : 1990) 2013;49(11):2522-30

Human papillomavirus (HPV) 16 E6 variants in tonsillar cancer in comparison to those in cervical cancer in Stockholm, Sweden
Du J, Nordfors C, Näsman A, Sobkowiak M, Romanitan M, Dalianis T, et al
PloS one 2012;7(4):e36239-

Prevalence of human papillomavirus (HPV) in oesophageal squamous cell carcinoma in relation to anatomical site of the tumour
Löfdahl He, Du J, Näsman A, Andersson E, Rubio Ca, Lu Y, et al
PloS one 2012;7(10):e46538-

Prevalence of oral human papillomavirus infection among youth, Sweden
Du J, Nordfors C, Ahrlund-richter A, Sobkowiak M, Romanitan M, Näsman A, et al
Emerging infectious diseases 2012;18(9):1468-71

Survival in patients with human papillomavirus positive tonsillar cancer in relation to treatment
Attner P, Näsman A, Du J, Hammarstedt L, Ramqvist T, Lindholm J, et al
International journal of cancer 2012;131(5):1124-30

Human papillomavirus and survival in patients with base of tongue cancer
Attner P, Du J, Nasman A, Hammarstedt L, Ramqvist T, Lindholm J, et al
INTERNATIONAL JOURNAL OF CANCER 2011;128(12):2892-7

Pre-vaccination prevalence of human papillomavirus types in the genital tract of 15-23-year-old women attending a youth health clinic in Stockholm, Sweden
Ramqvist T, Du Ja, Lunden M, Ahrlund-richter S, Ferreira J, Marions L, et al
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES 2011;43(2):115-21

Prevalence of Human Papillomavirus (HPV) types in cervical cancer 2003-2008 in Stockholm, Sweden, before public HPV vaccination
Du J, Nasman A, Carlson Jw, Ramqvist T, Dalianis T
ACTA ONCOLOGICA 2011;50(8):1215-9

Expression of IL-13Ralpha2 in liver cancer cells and its effect on targeted therapy of liver cancer
Hou L, Du J, Wang J, Liu Y, Sun W, Zheng Y, et al
Journal of cancer research and clinical oncology 2010;136(6):839-46

The role of human papillomavirus in the increased incidence of base of tongue cancer
Attner P, Du J, Nasman A, Hammarstedt L, Ramqvist T, Lindholm J, et al
INTERNATIONAL JOURNAL OF CANCER 2010;126(12):2879-84

Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral-induced carcinoma?
Nasman A, Attner P, Hammarstedt L, Do J, Eriksson M, Giraud G, et al
INTERNATIONAL JOURNAL OF CANCER 2009;125(2):362-6

Visa alla publikationer